Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Merck KGaA logo
MRK.DE
Merck KGaA
13:11:53
132.9
0.0000 (%0.00)
Previous Close: 133.05
Day Low132.4
Day High133.35
Bid
Ask

MRK.DE: Merck KGaA Stock Live Price Graph

Loading chart...
Industry
XETRA
Sector
-
Exchange
Deutsche Börse

About the company

Merck KGaA is a German science and technology company with operations divided into three core segments: Life Science, Healthcare, and Electronics. The Life Science division supplies essential tools, chemicals, and equipment to academic research institutions, biotechnology firms, pharmaceutical manufacturers, and various industrial sectors. It also offers specialized process development expertise, such as continuous bioprocessing for drug manufacturers, provides a range of testing kits, reagents, and services, and develops solutions for analyzing environmental samples like air, water, and soil. Furthermore, this segment aids in assessing nutritional value and identifying quality control issues. In its Healthcare segment, the company is involved in the entire lifecycle of prescription drugs and biopharmaceuticals, from initial discovery and development through manufacturing and marketing. Its therapeutic focus areas include oncology, neurology and immunology, fertility, endocrinology, cardiovascular diseases, diabetes, thyroid disorders, and multiple sclerosis. This segment also produces general medicines, injection devices, and software for disease monitoring. The Electronics division delivers critical materials for the semiconductor and display industries. It also specializes in surface design, providing delivery systems and services, along with a variety of surface solutions for applications such as cosmetics, effect pigments, and other functional materials. Merck KGaA is also actively engaged in strategic partnerships. These include in-licensing agreements with Debiopharm International SA for developing treatments for head and neck cancer, with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for metastatic colorectal cancer drug candidates, and with Abbisko Therapeutics Co. Ltd. for therapies targeting tenosynovial giant cell tumors. Additionally, the company is involved in collaborations focused on discovering and developing targeted protein degraders against critical oncogenic proteins. Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA operates as a subsidiary of E. Merck KG.

Company profile

Employees
59,020
Field of activity
Drug Manufacturers - Specialty & Generic

Market News & Analysis

Güçlü Sat
Sat
Nötr
Al
Güçlü Al

Target Price

No analyst target price data is available for this instrument.

Dividend History

Cash dividends

Latest dividend (gross per share)
$2.2
Highest dividend$2.2
Average dividend$2.2
Lowest dividend$2.2
PaymentGross / shareNet / shareYieldPer 1,000 TRY
-$2.2$2.22.02%-

What Is MRK.DE? Live MRK.DE Prices and Analysis

MRK.DE, also known as Merck KGaA, Darmstadt, Germany, is a leading global science and technology company in the healthcare, life science, and performance materials sectors. Founded in 1668, it has established a significant presence in the pharmaceutical and chemical industries, making it an essential player in the European market and beyond. Investors closely monitor MRK.DE for its potential growth, dividends, and overall market performance, as it reflects broader economic trends in the healthcare and technology sectors.

As a publicly traded company on the Frankfurt Stock Exchange, MRK.DE's stock offers investors a chance to partake in its growth trajectory, characterized by consistent innovation and strategic acquisitions.

Market Context

In the current global economic landscape, MRK.DE operates within a highly dynamic sector, influenced by international trading and the fluctuating pricing of pharmaceuticals and chemicals. The company's stock is primarily traded in Euros, and its performance can be affected by currency exchange rates, particularly the Euro against the US Dollar. Additionally, market volatility, driven by regulatory changes, global health crises, and technological advancements, plays a critical role in shaping investor sentiment towards MRK.DE.

Why Do MRK.DE Prices Rise or Fall?

The price of MRK.DE shares is influenced by a multitude of factors that investors need to consider when evaluating the stock. Understanding these factors can help investors make informed decisions regarding their investments.

  • Earnings Reports: Quarterly earnings can significantly impact stock prices, as they reflect the company's financial health.
  • Dividend Announcements: Regular dividends can attract income-focused investors, influencing stock demand.
  • Market Sentiment: Investor perception of the healthcare sector and Merck's position within it can lead to price fluctuations.
  • Regulatory Changes: New regulations or changes in drug approval processes can affect Merck's operations and profitability.
  • Research and Development Success: Breakthroughs in drug development or technology can enhance stock value.
  • Global Events: Health crises, such as pandemics, can increase demand for pharmaceuticals, positively impacting stock prices.
  • Economic Indicators: General economic conditions, including interest rates and inflation, can influence investor confidence.
  • Competitive Landscape: The performance of competitors in the pharmaceutical and life sciences sectors can affect MRK.DE’s market position.

In summary, MRK.DE's stock price is subject to a range of internal and external influences, making it essential for investors to stay informed about market trends and company-specific developments.

Why Is Live MRK.DE Price Tracking Important?

Tracking the live price of MRK.DE is crucial for both short-term traders and long-term investors. Real-time data allows investors to make timely decisions based on market movements and news developments. Here are some benefits of live price tracking:

  • Immediate Insight: Investors gain instant access to price changes, enabling swift decision-making.
  • Market Trends: Live tracking helps identify trends and patterns in stock performance.
  • Risk Management: Investors can set stop-loss orders based on real-time prices to mitigate potential losses.
  • Investment Opportunities: Monitoring price fluctuations can uncover potential buying or selling opportunities.
  • Informed Trading: Access to live data allows for more strategic trading decisions based on market conditions.

What Should You Consider When Trading / Investing in MRK.DE?

When considering an investment in MRK.DE, investors should weigh several factors that could impact their decision. Understanding inherent risks and market conditions is vital for effective trading.

  • Volatility: The healthcare sector can be volatile due to regulatory changes and market sentiment shifts.
  • Global Economic Data: Economic indicators, such as GDP growth and employment rates, can influence stock performance.
  • Company Fundamentals: Analyzing Merck's financial health through its earnings, P/E ratio, and dividend yield is essential.
  • Sector Trends: Keeping abreast of trends in the healthcare and life sciences sectors can provide insights into potential growth.
  • Risk Appetite: Investors should assess their risk tolerance before investing in MRK.DE.

What Can You Find on the Investvio MRK.DE Page?

  • Live MRK.DE price and historical data
  • Comprehensive charts and technical analysis
  • Latest news and updates regarding Merck KGaA
  • Earnings reports and dividend announcements
  • Market sentiment analysis and expert opinions

In conclusion, MRK.DE represents a compelling investment opportunity within the healthcare sector. By utilizing the resources available on the Investvio MRK.DE page, investors can stay informed and make strategic decisions regarding their investments in this established company.